Rajesh Kumar Chopra Steps Down As Vice President Of Manufacturing Excellence Of Panacea Biotec

Rajesh Kumar Chopra, Vice President of Manufacturing Excellence (Senior Management Personnel) of Panacea Biotec Limited, has tendered his resignation due to personal reasons with a request to relieve him from the duties on or before December 31, 2024.

Chopra has over 15 years of experience in biotech R&D and vaccine manufacturing, having led key initiatives in the industry. He was head of the Vaccine Formulation Plant at Panacea Biotec, focusing on vaccine formulation and filling. Rajesh has successfully led teams for technology transfers, scale-ups, and clinical trial material preparation. His expertise includes media fill validation, aseptic formulation system validation, and WHO audit preparations, securing prequalification certificates for vaccines.